West Pharmaceutical Services, Inc.'s Q2 results highlight growth driven by GLP-1 drugs and high-value products. Click for WST ...

Q2 2025 Earnings Call Transcript July 24, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported EPS ...

Alabama, Indiana, Missouri, Tennessee, Texas and Utah also have scheduled executions for later this year.     Executions have been carried out this year in Alabama, Arizona, Florida, Indiana, ...

WASHINGTON, DC (IANS) – Drug makers Dr Reddy’s Laboratories, Sun Pharma and Aurobindo Pharma are recalling their products in the US due to manufacturing issues.

RFK Jr. pledges to challenge Big Pharma and Big Food, advocating for health, transparency, and accountability. Discover his vision for a healthier America.

Andembry is administered subcutaneously using an auto-injector pen and provides less frequent dosing than Takeda's $1.2 billion-selling kallikrein inhibitor Takhzyro (lanadelumab), which requires ...

GCQ25 | A complete Gold Aug 2025 futures overview by MarketWatch. View the futures and commodity market news, futures pricing and futures trading.

EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) raised its full-year revenue and earnings guidance following a ...